These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31037707)

  • 21. Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors.
    Walter T; Bruneton D; Cassier PA; Hervieu V; Pilleul F; Scoazec JY; Chayvialle JA; Lombard-Bohas C
    Clin Colorectal Cancer; 2010 Oct; 9(4):248-54. PubMed ID: 20920998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292.
    Sparano JA; Lipsitz S; Wadler S; Hansen R; Bushunow PW; Kirkwood J; Flynn PJ; Dutcher JP; Benson AB
    Am J Clin Oncol; 1996 Dec; 19(6):546-51. PubMed ID: 8931668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chemotherapy of neuroendocrine tumors].
    Droz JP; Flechon A; Lombard-Bohas C
    Rev Prat; 2002 Feb; 52(3):285-9. PubMed ID: 11925719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsurgical treatment of advanced malignant neuroendocrine pancreatic tumors and midgut carcinoids.
    Skogseid B
    World J Surg; 2001 Jun; 25(6):700-3. PubMed ID: 11376401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?
    Lamarca A; Elliott E; Barriuso J; Backen A; McNamara MG; Hubner R; Valle JW
    Cancer Treat Rev; 2016 Mar; 44():26-41. PubMed ID: 26855376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metastatic pancreatic neuroendocrine tumors and chemotherapy: evidences and perspectives].
    Gómez Raposo C; Gómez Senent S; González Barón M
    Med Clin (Barc); 2007 Mar; 128(9):357; author reply 357-8. PubMed ID: 17376367
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors.
    Cheng YJ; Meng CT; Ying HY; Zhou JF; Yan XY; Gao X; Zhou N; Bai CM
    Medicine (Baltimore); 2018 Nov; 97(45):e12750. PubMed ID: 30407280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma.
    Ducreux M; Rougier P; Pignon JP; Douillard JY; Seitz JF; Bugat R; Bosset JF; Merouche Y; Raoul JL; Ychou M; Adenis A; Berthault-Cvitkovic F; Luboinski M;
    Ann Oncol; 2002 Aug; 13(8):1185-91. PubMed ID: 12181240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation.
    Dousset B; Saint-Marc O; Pitre J; Soubrane O; Houssin D; Chapuis Y
    World J Surg; 1996 Sep; 20(7):908-14; discussion 914-5. PubMed ID: 8678970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy in the management of pancreatic neuroendocrine tumors (PNET): experience at three institutions.
    Saif MW; Ove R; Ng J; Russo S
    Anticancer Res; 2013 May; 33(5):2175-7. PubMed ID: 23645772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic chemotherapy for pancreatic neuroendocrine tumors.
    Okusaka T; Ueno H; Morizane C; Kondo S; Sakamoto Y; Takahashi H; Ohno I; Shimizu S; Mitsunaga S; Ikeda M
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):628-33. PubMed ID: 25940377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy in the treatment of neuroendocrine malignant tumors.
    Rougier P; Mitry E
    Digestion; 2000; 62 Suppl 1():73-8. PubMed ID: 10940691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
    White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D
    Ann Surg Oncol; 1999; 6(1):38-45. PubMed ID: 10030414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer.
    Mehta VK; Poen JC; Ford JM; Oberhelman HA; Vierra MA; Bastidas AJ; Fisher GA
    Am J Clin Oncol; 2001 Apr; 24(2):155-9. PubMed ID: 11319291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
    Ahmed S; Vaitkevicius VK; Zalupski MM; Du W; Arlauskas P; Gordon C; Kellogg C; Shields AF
    Am J Clin Oncol; 2000 Aug; 23(4):420-4. PubMed ID: 10955876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy.
    Cooperman AM; Snady H; Bruckner HW; Hammerman H; Siegel J; Stark B; Bank S
    Surg Clin North Am; 2001 Jun; 81(3):699-708. PubMed ID: 11459283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
    Fine RL; Gulati AP; Krantz BA; Moss RA; Schreibman S; Tsushima DA; Mowatt KB; Dinnen RD; Mao Y; Stevens PD; Schrope B; Allendorf J; Lee JA; Sherman WH; Chabot JA
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):663-70. PubMed ID: 23370660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin.
    Gonzalez MA; Biswas S; Clifton L; Corrie PG
    Br J Cancer; 2003 Aug; 89(3):455-6. PubMed ID: 12888810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan.
    Aoki T; Kokudo N; Komoto I; Takaori K; Kimura W; Sano K; Takamoto T; Hashimoto T; Okusaka T; Morizane C; Ito T; Imamura M
    J Gastroenterol; 2015 Jul; 50(7):769-75. PubMed ID: 25348496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Chemotherapy for unresectable pancreatoblastoma".
    Hord JD; Janco RL
    Med Pediatr Oncol; 1996 Jun; 26(6):432-3. PubMed ID: 8614383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.